{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:11:09Z","timestamp":1759342269078,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1124\/dmd.112.048231","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T05:23:50Z","timestamp":1354857830000},"page":"518-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Compartmental and Enzyme Kinetic Modeling To Elucidate the Biotransformation Pathway of a Centrally Acting Antitrypanosomal Prodrug"],"prefix":"10.1016","volume":"41","author":[{"given":"Claudia N.","family":"Generaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett R.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene S.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Boykin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Tidwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhiren R.","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary F.","family":"Paine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.048231_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/00498250500087671","article-title":"In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis","volume":"35","author":"Ansede","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.048231_bib2","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.envpol.2009.04.019","article-title":"Metabolites of the phenylurea herbicides chlorotoluron, diuron, isoproturon and linuron produced by the soil fungus Mortierella sp","volume":"157","author":"Badawi","year":"2009","journal-title":"Environ Pollut"},{"key":"10.1124\/dmd.112.048231_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.trstmh.2008.09.005","article-title":"Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine M\u00e9decins Sans Fronti\u00e8res programmes","volume":"103","author":"Balasegaram","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/dmd.112.048231_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.112.048231_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/pest.1998.2324","article-title":"Parameters influencing biotransformation rates of phenylurea herbicides by soil microorganisms","volume":"60","author":"Berger","year":"1998","journal-title":"Pestic Biochem Physiol"},{"key":"10.1124\/dmd.112.048231_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/jm00006a009","article-title":"Dicationic diarylfurans as anti-Pneumocystis carinii agents","volume":"38","author":"Boykin","year":"1995","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.112.048231_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1023\/B:PHAM.0000026420.79421.8f","article-title":"The complexities of hepatic drug transport: current knowledge and emerging concepts","volume":"21","author":"Chandra","year":"2004","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.048231_bib8","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1124\/dmd.105.005249","article-title":"Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid)","volume":"33","author":"Clement","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.048231_bib9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s11095-007-9239-y","article-title":"Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists","volume":"24","author":"Gong","year":"2007","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.048231_bib10","doi-asserted-by":"crossref","first-page":"34796","DOI":"10.1074\/jbc.M607697200","article-title":"Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme","volume":"281","author":"Havemeyer","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.048231_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jlcr.1111","article-title":"Synthesis of deuterium and 15N-labelled 2,5-Bis[5-amidino-2-pyridyl]furan and 2,5-Bis[5-(methoxyamidino)-2-pyridyl]furan","volume":"49","author":"Ismail","year":"2006","journal-title":"J Label Compd Radiopharm"},{"key":"10.1124\/dmd.112.048231_bib12","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/jm0302602","article-title":"Synthesis and antiprotozoal activity of aza-analogues of furamidine","volume":"46","author":"Ismail","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.112.048231_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1124\/dmd.105.003715","article-title":"Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm","volume":"33","author":"Ito","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.048231_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.112.048231_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0006-2952(97)00204-9","article-title":"Drug metabolism in hepatocyte sandwich cultures of rats and humans","volume":"54","author":"Kern","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.048231_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1473-3099(02)00321-3","article-title":"Treatment of human African trypanosomiasis: present situation and needs for research and development","volume":"2","author":"Legros","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1124\/dmd.112.048231_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pt.2003.12.004","article-title":"Antigenic variation in African trypanosomes: monitoring progress","volume":"20","author":"McCulloch","year":"2004","journal-title":"Trends Parasitol"},{"key":"10.1124\/dmd.112.048231_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj1950761","article-title":"Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole: isolation of an NN-bridged benzyne-protoporphyrin IX adduct","volume":"195","author":"Ortiz de Montellano","year":"1981","journal-title":"Biochem J"},{"key":"10.1124\/dmd.112.048231_bib19","first-page":"876","article-title":"Diamidines for human African trypanosomiasis","volume":"11","author":"Paine","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/dmd.112.048231_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1124\/dmd.112.048231_bib21","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1074\/jbc.M709783200","article-title":"Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2: highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding","volume":"283","author":"Sohl","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.048231_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0141-9838.2004.00731.x","article-title":"Human African trypanosomiasis: clinical presentation and immune response","volume":"26","author":"Sternberg","year":"2004","journal-title":"Parasite Immunol"},{"key":"10.1124\/dmd.112.048231_bib23","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1124\/dmd.106.010587","article-title":"CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]","volume":"34","author":"Wang","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.048231_bib24","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/AAC.00225-09","article-title":"New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289","volume":"53","author":"Wenzler","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.112.048231_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ph2030077","article-title":"A new classification of prodrugs: regulatory perspectives","volume":"2","author":"Wu","year":"2009","journal-title":"Pharmaceuticals"},{"key":"10.1124\/dmd.112.048231_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2007.04.005","article-title":"Regulatory perspectives of type II prodrug development and time-dependent toxicity management: nonclinical pharm\/tox analysis and the role of comparative toxicology","volume":"236","author":"Wu","year":"2007","journal-title":"Toxicology"},{"key":"10.1124\/dmd.112.048231_bib27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.103.059626","article-title":"Catalytic activity and isoform-specific inhibition of rat cytochrome P450 4F enzymes","volume":"308","author":"Xu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.048231_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/prep.2001.1578","article-title":"Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli","volume":"24","author":"Yamazaki","year":"2002","journal-title":"Protein Expr Purif"},{"key":"10.1124\/dmd.112.048231_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1124\/jpet.110.177220","article-title":"Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models","volume":"337","author":"Yan","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.048231_bib30","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1023\/A:1020957430400","article-title":"Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug","volume":"19","author":"Zhou","year":"2002","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.048231_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jms.591","article-title":"Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography\/tandem mass spectrometry","volume":"39","author":"Zhou","year":"2004","journal-title":"J Mass Spectrom"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624116297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624116297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.048231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:42:05Z","timestamp":1739907725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624116297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0090955624116297"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.048231","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compartmental and Enzyme Kinetic Modeling To Elucidate the Biotransformation Pathway of a Centrally Acting Antitrypanosomal Prodrug","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.048231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}